STAT+: FDA clears Capsida gene therapy for clinical trials
And other biotech updates brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hullo! Today, we look at health secretary RFK Jr.’s handpicked members of a vaccine advisory committee, see Sen. Bill Cassidy quietly explore a “most-favored nation” pricing policy for prescription drugs, and more.
The need-to-know this morning
- BioNTech, the German maker of mRNA-based vaccines and drugs, is acquiring fellow German drug developer CureVac in an all-stock deal valued at $1.25 billion.
RFK Jr. installs vaccine critics on CDC panel
Health secretary Robert F. Kennedy Jr. yesterday appointed a new, smaller vaccine advisory committee at the CDC — just two days after firing every member of the panel, the Advisory Committee on Immunization Practices, and calling for a “clean slate.”
